Patients With A High-Risk Common Type COVID-19 Pneumonia May Be the Optimal Time for Methylprednisolone Therapy: A Retrospective Cohort Study
Lei Liu(Hunan Agricultural University), Wei Zhang(Shihezi University), Wen‐yan Gong(Mudanjiang Medical University), Jian‐Jun Li(Lianyungang Oriental Hospital), Weiyan Yang(Harbin Medical University), Xi-Qiu Zeng(Mudanjiang Medical University), Hang Qu(Anhui University of Science and Technology), Zhi-Zhong He(Mudanjiang Medical University), B. Liu(Nanjing Drum Tower Hospital), Chun-Li Che(Harbin Medical University), Heyi Zhang(Mudanjiang Medical University)
Cited by 0
Related Papers
Nanotechnology in Textiles
|ACS Nano|2016|747
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
|Journal of Allergy and Clinical Immunology|2020|694
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556
Refractive Error in Urban and Rural Adult Chinese in Beijing
|Ophthalmology|2005|273